TITLE

PEOPLE IN PLACES

PUB. DATE
October 2007
SOURCE
Medical Device Daily;10/18/2007, Vol. 11 Issue 200, p10
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article announces the appointments of Charles Harwood and Ron Sparks as healthcare industry advisors for Avista Capital Partners, Ronald Green as CEO of Barnev, and Todd Wood as vice president of operations and acting CFO of Biopure.
ACCESSION #
27165968

 

Related Articles

  • 'Non-strategic' sales initiative completed by Boston Scientific. Johnson, Holland // Cardiovascular Devices & Drugs;Jan2008, Vol. 14 Issue 1, p23 

    The article reports that Boston Scientific has signed an agreement to sell its fluid management and venous access businesses for $425 million in cash to privately equity firm Avista Capital Partners. The company plans to divest five units that it termed not core to its primary business goals....

  • Bristol-Myers to sell its ConvaTec unit.  // Medical Technology & Devices Week;5/12/2008, Vol. 6 Issue 19, p3 

    This article reports on the move of Bristol-Myers Squibb to sign a definitive agreement to sell its ConvaTec business unit to private equity firms Nordic Capital Fund VII and Avista Capital Partners. Accordingly, the deal is worth $4 billion. The reason of Bristol-Myers Squibb for selling...

  • Boston Scientific closes sale of 2 units to Avista for $425 million.  // Medical Device Daily;2/15/2008, Vol. 12 Issue 32, p1 

    The article reports on the completion of the sale of Boston Scientific's Fluid Management and Venous Access businesses to Avista Capital Partners. Boston claims that the sale has divested all five nonstrategic units it had previously planned to divest and it expects to record an after-tax gain...

  • Boston Sci divests 2 businesses to Avista for $425 million in cash. Johnson, Holland // Medical Device Daily;12/17/2007, Vol. 11 Issue 228, p1 

    The article reports that Boston Scientific has signed a deal to sell its fluid management and venous access businesses for $425 million in cash to private equity company Avista Capital Partners. The deal is expected to be finalized in the first quarter of 2008. Boston Scientific's intent to sell...

  • Boston Scientific closes sale of 2 units for $425M.  // Medical Technology & Devices Week;2/19/2008, Vol. 6 Issue 7, p5 

    This article reports on the sale of the Fluid Management and Venous Access businesses of Boston Scientific to Avista Capital Partners. The business units were sold for $425 million. Boston Scientific sold the business units a part of its plan to divest non-strategic assets. According to Jim...

  • Avista Closes $2bn Debut. MacFadyen, Ken // Mergers & Acquisitions: The Dealermaker's Journal;Aug2007, Vol. 42 Issue 8, p32 

    The article focuses on the approach taken by Thompson Dean, founder of Avista Capital Partners, to close his debut fund. Dean simply moved ahead with the dealmaking, and let the remaining holdouts see for themselves if his past performance at DLJ Merchant Banking would carry over. Also discussed...

  • Subsidiary For Sale: Invitrogen Corp. Graves, Brad // San Diego Business Journal;2/19/2007, Vol. 28 Issue 8, p46 

    The article announces the plan of Invitrogen Corp. to sell its business unit, BioReliance Corp. to Avista Capital Partners company in Carlsbad, California. Invitrogen is selling the business for $210 million. The seller also disclosed that it had posted a net loss of $191 million and revenue of...

  • Avista nets 2 Boston Sci businesses for $425M.  // Medical Technology & Devices Week;12/26/2007, Vol. 5 Issue 50, p2 

    The article reports on the agreement signed by Boston Scientific to sell its fluid management and venous access businesses for $425 million in cash to Avista Capital Partners, a private equity firm in the U.S. According to reports, the transaction is expected to close in the first quarter of...

  • Navilyst formed by spin-off of several Boston Scientific assets.  // Medical Device Daily;8/5/2008, Vol. 12 Issue 150, p3 

    The article focuses on Navilyst Medical, a spun off company formed by Boston Scientific, in August 2008. The company's assets include Boston Scientific's old fluid management and vascular access business, purchased by private equity company Avista Capital Partners in February. Navilyst is...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics